Evaluation of natural killer cell activity in pre and post treated breast cancer patients

Journal of Cancer Research and Therapeutics

Volumn 6, Issue 4, 2010, Pages 478-481

  Piroozmand, Ahmad ^a   Hassan, Zuhair M ^b  

^a KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Breast cancer; flowcytometry; mastectomy; natural killer Cell

Indexed keywords

FICOLL;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CANCER RESEARCH; CANCER STAGING; CELL ISOLATION; CELL STRAIN K 562; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTRADUCTAL CARCINOMA; MASTECTOMY; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; TREATMENT OUTCOME;

ADULT; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; FLOW CYTOMETRY; HUMANS; KILLER CELLS, NATURAL; MASTECTOMY; MIDDLE AGED;

EID: 79952371316     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.77110     Document Type: Article

References (26)

1. Brodt P. Tumor immunology: Three decades in review. Ann Rev Microbiol 1983;37:447-76.
2. Levy S, Tempé JL, Caussade P, Aleksijevic A, Grosshans E, Mayer S, et al. Stage - related decrease in natural killer cell activity in untreated patients with mycosis fungoides. Cancer Immunol Immunother 1984;18:138-40. (Pubitemid 15213369)
3. Fodstad O, Hansen CT, Cannon GB, Statham CN, Lichtenstein GR, Boyd MR. Lack of correlation between NK-activity and tumor growth control in nude mice with different immune defects. Cancer Res 1984;44:4403-8. (Pubitemid 14008756)
4. Healy F, Rees RC, Hancock BW. An assessment of natural killer cell mediated cytotoxicity in patients with malignant lymphoma. Eur J Cancer Oncol 1985;21:775-83. (Pubitemid 15028502)
5. Hokland M, Jacobsen N, Ellegaard J, Hokland P. Natural killer Function following allogeneic bone marrow transplantation. Transplantation 1988;45:1080-5.
6. Whiteside TL, Herberman RB. The role of natural killer cells in immune surveilance of cancer. Curr Opin Immunol 1995;7:704-10.
7. Smyth MJ, Thia Ky, Cretney E, Kelly JM, Snook MB, Forbes CA, et al. Perforin is a major contributor to NK cell control of tumor metastasis. J Immunol 1999;162:6658-62. (Pubitemid 29309390)
8. Divino CM, Chen SH, Yang W, Thung S, Brower S, Woo LC. Anti-tumor immunity induced by interleukin-12 gene therapy in a metastatic model of breast cancer is mediated by natural killer cells. Breast Cancer Res Treat 2000;60:129-34. (Pubitemid 30307472)
9. Whiteside TL. Herberman RB. The role of NK cells in human disease. Clin Immunol Immunopath 1989;53:1-23. (Pubitemid 19232003)
10. Mozaffari F, Lindemalm C, Choudhury A, Granstam-Bjorneklett H, Helander I, Lekander M. NK-cell and T-cell functions in patients with breast cancer: Effects of surgery and adjuvant chemo-and radiotherapy. Br J Cancer 2007;97:105-11. (Pubitemid 47012095)
11. Kono K, Takahashi A, Ichihara F, Sugai H, Fujii H, Matsumoto Y. Impaired antibody-dependent cellular cytotoxicity mediated by herceptin in patients with gastric cancer. Cancer Res 2002;62:5813-7. (Pubitemid 35204740)
12. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Invest 1968;97:77-89.
13. Vitale M, Neri LM, Comani S, Falcieri E, Rana R, Papa S. Natural Killer function in flow-cytometry. II. Evaluation of NK lytic activity by means of target cell morphological changes detected by right angle light scatter. J Immunol Methods 1989;121:115-20. (Pubitemid 19174098)
14. Vitale M, Papa S, Martiani AR, Facchini A, Rizzoli R, Manzoli FA. Use of polygonal windows for physical discrimination among mononuclear subpopulation in flow cytometry. J Immunol Methods 1987;96:638.
15. Papa S, Vitale M, Mariani AR, Roda P, Facchini A, Manzoli FA. Natural killer function in flow cytometry. I. Evaluation of NK lytic activity on K562 cell line. J Immunol Methods 1988;107:73-8. (Pubitemid 18060369)
16. Hanna N. Expression of metastatic potential of tumor cells in young nude mice is correlated with low levels of natural killer cell-mediated cytotoxicity. Int J Cancer 1980;26:675-80. (Pubitemid 11234003)
17. Hanna N. Role of natural killer cells in control of cancer metastasis. Cancer Metastasis Rev 1982;1:45-64.
18. Hanna N. Inhibition of experimental tumor metastasis by selective activation of natural killer cells. Cancer Res 1982;42:1337-42. (Pubitemid 12148773)
19. Manna N, Fidler IJ. Rote of natural killer cells in the destruction of circulating tumor emboli. J Nati Cancer Inst 1980;65:801-9. (Pubitemid 10059970)
20. Cole WH. Dissemination of Cancer the colon. Gastroenterology 1961;41:412-4.
21. Sheikhi A. The assessment of NK cell activity in cancer patients and its comparison with normal persons. PhD dissertation 1994;60-8.
22. Konjević G, Jurisić V, Spuzić I. Association of NK cell dysfunction with changes in LDH characteristics of peripheral blood lymphocytes (PBL) in breast cancer patients. Breast Cancer Res Treat 2001;66:255-63. (Pubitemid 32675028)
23. Hoek A, Van Kasteren Y, De Haan-Meulman M, Hooijkaas H, Schoemaker J, Drexhage H. Analysis of peripheral blood lymphocyte subsets, NK cells, and delayed type hypersensitivity skin test in patients with premature ovarian failure. Am J Reprod Immunol 1995;33:495-502.
24. Lukac J, Kusic Z, Kordic D, Koncar M, Bolanca A. Natural killer cell activity, phagocytosis, and number of peripheral blood cells in breast cancer patients treated with tamoxifen. Breast Cancer Res Treat 1994;29:279-85. (Pubitemid 24135823)
25. Konjević G, Spuzić I. The effect of sera of breast cancer patients on NK cell activity. Srp Arh Celok Lek 1995;123:227-31.
26. Zarcone D, Tilden AB, Cloud G, Friedman HM, Landay A, Grossi CE. Flow cytometry evaluation of cell mediated cytotoxicity. J Immunol Methods 1986;94:247-55. (Pubitemid 17186366)